Shionogi to increase stake in Apnimed within 6 months of IPO
Resolves: Shionogi publicly announces an increased ownership stake in Apnimed (via SEC filing or press release) within 6 months of Apnimed's IPO completion.
user-generated· regulatory
Shionogi to increase stake in Apnimed within 6 months of IPO
Market overview
Shionogi's strategic investment in Apnimed's IPO filing demonstrates long-term commitment. Given the drug's potential, Shionogi is likely to bolster its ownership to secure control and commercial rights.
regulatory prediction market
- Implied probability (Yes)
- 60%
- Closes
- 2027-01-10
About this prediction
Resolution criteria
Shionogi publicly announces an increased ownership stake in Apnimed (via SEC filing or press release) within 6 months of Apnimed's IPO completion.
Source: user-generated
More regulatory markets
- Crypto billionaire Harborne faces FCA scrutiny over £5m gift — 55% Yes
- Crypto billionaire Harborne will face FCA scrutiny — 60% Yes
- Crypto billionaire Christopher Harborne’s donation triggers FCA inquiry into funding transparency — 70% Yes
- Crypto billionaire Christopher Harborne will face parliamentary scrutiny over £5m gift — 55% Yes
- Harborne crypto holdings face regulatory scrutiny — 60% Yes
- SEC approves at least 2 new Bitcoin ETFs by Q4 2027 — 75% Yes
- SEC approves Kalshi's crypto futures products by 2026-Q3 — 55% Yes
- Iran's central bank bans crypto mining by 2027 Q1 — 85% Yes
No one's made a Conviction call on this yet. Be the first to call it →
Loading…